Publication | Open Access
Tryptophan potentiates CD8<sup>+</sup> T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation
90
Citations
40
References
2021
Year
Our results revealed the immune-activating efficacy of tryptophan, and suggested tryptophan supplemental may benefit IDO inhibitors and PD-1 blockade during anticancer treatments.
| Year | Citations | |
|---|---|---|
Page 1
Page 1